 "Industry opposes move to control stent prices")
The Shanghai-based MicroPort Scientific Corporation has entered the Indian market within days of the National Pharmaceutical Pricing Authority (NPPA) imposing a cap on prices of coronary stents. This is in contrast to global giants like Abbott, which are finding it difficult to maintain their premium biodegradable stents in the market, according to distributors.
The NPPA on February 13 capped the prices of bare metal stents at Rs 7,260 and those of drug eluting stents, used in about 90 per cent of angioplasty procedures, at Rs 29,600. The more advanced biodegradable stents introduced in India in the last two years were also
